Patent: 7,963,946
✉ Email this page to a colleague
Summary for Patent: 7,963,946
Title: | Method and system for controlled infusion of therapeutic substances |
Abstract: | Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects. |
Inventor(s): | Moubayed; Ahmad-Maher (Mission Viejo, CA), Hyman; Oscar E. (Poulsbo, WA), White; David N. (San Juan Capistrano, CA), Wilson; Larry L. (Poway, CA), Stevenson; John W. (Carlsbad, CA), Moubayed; Jay G. (Aliso Viejo, CA), Thomas; Linda (Laguna Niguel, CA) |
Assignee: | Baxter International Inc. (Deerfield, IL) Baxter Healthcare S.A. (Glattpark (Opfikon), CH) |
Application Number: | 11/731,585 |
Patent Claims: | see list of patent claims |
Details for Patent 7,963,946
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2026-09-18 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 05/21/2004 | ⤷ Try a Trial | 2026-09-18 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 03/26/2007 | ⤷ Try a Trial | 2026-09-18 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 07/11/2014 | ⤷ Try a Trial | 2026-09-18 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |